Browse Studies — Arctuva

Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Phase 2 Study of Efficacy and Safety of Tirzepatide in Individuals With Alcohol Use Disorder and Metabolic Alcohol-associated Liver Disease

Background: People with alcohol use disorder (AUD) often develop metabolic alcohol-associated liver disease (MetALD). MetALD is a term for the heart, liver, o…

Metabolic Alcohol-associated Liver DiseaseAlcohol Use Disorder

Estimated

~$10 – $5,625

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT07046819

Supplementation of Pomegranate Dietary Supplements and Characterization of Urolithin Metabotypes in Patients With Alcohol Use Disorder (AUD) and Alcohol-associated Liver Disease (ALD)

The goal of this project is to determine an individual's ability to generate active gut microbial metabolites called urolithins upon consumption of pomegranate…

Alcohol Use DisorderAlcohol-associated Liver DiseaseAlcoholic Cirrhosis+1 more

Estimated

~$10 – $750

University of LouisvilleNCT07678567

Observational

Feasibility and Acceptability of a Novel Implementation Intervention to Promote Alcohol Use Disorder Treatment in Hepatology Clinics

The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use …

Alcohol Use DisorderAlcohol-associated Liver Disease

Estimated

~$10 – $6,250

Yale UniversityNCT07525258

Phase 2

Lactobacillus Rhamnosus GG: A Novel Probiotic Therapy for Treating Alcohol Use Disorder

To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder (AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate …

Alcohol Use DisorderAlcohol-associated Liver Disease

Estimated

~$10 – $6,250

University of LouisvilleNCT05178069